HealthData.Gov
Synthesis and preliminary cytotoxicity study of a cephalosporin-CC-1065 analogue prodrug
Background Antibody-directed enzyme prodrug therapy (ADEPT) is a promising new approach to deliver anticancer drugs selectively to tumor cells. In this approach, an enzyme is conjugated to a tumor-specific antibody. The…
- HTML
Updated Oct 29, 2026